Background: The role of miR-1 and miR-133 in regulating the expression of
Introduction
MicroRNA (miR)-1 and miR-133 are members of a miRNA cluster expressed exclusively in skeletal and cardiac muscle cells [1] , and are essential for heart development [2] . MiR-1 and miR-133 have been shown to regulate the expression of gap junctions [3] , pacemaker channels [4] and potassium (K + ) channels, including inward-rectifying Kir2.1, which stabilizes resting potential [5] and Kv4.2, which dominates the outward-transient current (Ito) [6] . In addition, miR-133 has been shown to target CaV1.2, the primary α-subunit for L-type calcium (Ca 2+ ) channels underlying cardiac excitability [7] . Previous studies have shown that approximately 20% of infant deaths due to fatal arrhythmia and severe heart failure were caused by acute severe viral myocarditis (VMC), mainly caused by coxsackievirus B3 (CVB3) [8] .
However, there is currently a lack of effective etiological treatment for severe VMC.
Introducing miR-1/133 can reduce virus escape and mutation, and as such, one of the major treatments involves the use of RNA interference (RNAi) combined with miR mimics [9, 10] . A previous study showed that approximately 20% of miR-1/133 mimics, labeled with Dy547 and packaged in RNA-LANCEr II neutral ionic lipids, arrived in cardiomyocytes and exhibited intracellular Dy547 particle signals when administered by tail vein injection [10] . In addition, miR-133 has been shown to target caspase-9, a pro-apoptotic factor, and promotes cardiac cell apoptosis by interfering with the expression of mRNA [11] .
With rapid advances in molecular biology, miRs have been widely studied in different fields. However, reports regarding the effects of miRs on VMC have been limited. Under investigation in the present study, was the impact of miR-1/133 mimics and the appropriate miR-1/133 negative control on a mouse model of acute VMC, and the hypothesis that miR-1 and miR-133 could etiologically help to treat severe VMC was examined.
Methods
This study was in accordance with the National Research Council Guide for the care and use of laboratory animals. The animal experiments in this study were performed with approval by the Animal Care Committee of the Medical School of Shandong University.
Mouse model of acute VMC and interference
CVB3 was passaged in HeLa cells by transfection as described previously [12] .
Virus titer was determined using a tissue culture infective dose 50 (TCID50) assay at the beginning of the experiments. HeLa cells were cultured in Dulbecco's Modified
Eagle medium (DMEM, Life Technologies, USA) supplemented with fetal bovine serum (10%; Gibco, Australia) and penicillin-streptomycin (100 IU/mL; Invitrogen, USA).
Forty healthy male Balb/c mice (6-8 weeks old) were randomly divided into four groups: control group (n = 10), in which mice were injected intraperitoneally with Eagle's medium (0.1 mL); VMC group (n = 10), in which VMC was induced by intraperitoneal injection of 10 4 TCID50 CVB3 (0.1 mL); VMC + miR-1/133 mimics group (n = 10), in which VMC mice were injected intraperitoneally with miR-1/133 mimics (1 µg/g, GenePharma, Shanghai, China) on the day following VMC induction;
VMC + NC group (n = 10), in which VMC mice were injected intraperitoneally with miR-1/133 NC (1 µg/g, GenePharma, Shanghai, China) via the tail vein on the day following VMC induction.
MiR-1/133 mimics, which were composed of mmu-miR-1 mimics and mmu-miR-133 mimics, were packaged in Lipofectamine 2000 Reagent (Invitrogen, US), and then directly mixed in the ultrasonic field to improve targeting ability.
Feeding conditions of mice in each group were the same. Following virus injection, the diet, activity level, and coat appearance of the mice were observed on a daily basis.
Cardiac functional analysis
On the 7 th day following establishment of the VMC model, i.e. the sixth day after mir-1/133 intervention, mice were anesthetized with an intraperitoneal injection of chloral hydrate (10%, 4 mg/g). After the mice were fixed in a supine position, the chest was shaved, and an M-echocardiograph was performed to measure the left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) of the mice in each group.
Specimen collection and disposition
On the 7 th day after modeling, after all mice in the groups were anesthetized, their hearts were removed under sterile conditions, washed with normal saline, and then weighed. Half of each heart of the mice were frozen with liquid nitrogen and stored at -80C for use in molecular biological experiments (half of each heart was used for quantitative reverse transcription followed by polymerase chain reaction (qRT-PCR) and western blot, which were carried out by two people), the other half of the heart were fixed in 10% neutral formaldehyde, embedded in paraffin, and sectioned at 4.5 µm intervals for histological study (HE staining and TUNEL staining).
Hematoxylin and eosin staining
Tissue sections were stained by hematoxylin and eosin (H&E; Beyotime, Shanghai, China), and cardiomyocyte morphology changes were observed under a light microscope.
TUNEL staining
Cardiomyocyte apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining according to the manufacturer protocol (Roche, USA). Ten randomly selected fields from each slide were scored at a high magnification. The ratio of the number of brown cells, i.e. apoptotic cells, to a total of 30 cardiomyocytes counted per field was defined as the myocardial cell apoptotic ratio.
Quantitative real time RT-PCR
Total RNA was extracted from a part of each of frozen mouse heart using a TRIzol reagent (Ambion, USA). According to the manufacturer protocol (Thermo Scientific, USA), qRT-PCR was performed to detect the expression of miR-1 and miR-133, inward rectifier potassium current (Ik1) channel gene Kcnd2, its transcription repressor
Irx5, transient outward potassium current (Ito) channel gene Kcnj2, the L-type calcium channel subunit α1c (Cacna1c), and apoptosis-related genes Bax, Bcl-2 and caspase-9 (Casp9) using an ABI 7500 real-time PCR system. β-actin was used as a reference for gene expression and U6 was used as a reference for expression of miR-1 and miR-133.
The relative expression of genes was calculated using the 2 -∆∆Ct method. The primers were synthesized by Guangzhou Saibo Corp, China. The sequences of gene primers used in the present study are shown in Table 1 .
Western blot
To examine protein levels of Kv4.2, Kir2.1, and CaV1.2, total protein lysates were purified from the rest of frozen heart samples using RIPA buffer (Beyotime, Shanghai, China). A bicinchoninic acid (BCA) protein assay kit (Beyotime, Shanghai, China) was used to determine protein concentration. Protein (30-50 µg) was separated on an 8-15% gel with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene fluoride (PVDF) membrane. The membrane was then blocked in 5% milk, followed by incubation at 4C overnight with the primary antibodies of interest (rabbit polyclonal anti-Kv4.2 and anti-Kir2.1, Bioss, Beijing, China, diluted 1:300; mouse monoclonal anti-CACNA1C, Abcam, USA; and mouse anti-GAPDH, ZSGB-BIO Beijing, China, diluted 1:1000). Membranes were then washed (3 times) with tris-buffered saline with Tween (TBST), and incubated with the appropriate secondary antibodies (ZSGB-BIO Beijing, China, diluted 1:10000).
Immunoreactive bands were detected by enhanced chemiluminescence (ECL;
Millipore, USA) and quantified using C-digit (Model: 3600, Image Studio Digits Ver 4.0, Licor, Lincoln, NE, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a reference loading control. Data were collected from at least three independent experiments.
Data analysis
The experimental data are presented as mean ± standard error (SE). Statistical comparisons in multiple groups were performed using one-way analysis of variance (ANOVA), and the comparison between two groups was performed with the Fisher least significant difference (LSD)-t test. A probability value of p < 0.05 was considered statistically significant.
Results

MiR-1/133 mimics improved general status of VMC mice
Compared with mice in the control group, on the third day following CVB3
injection, mice in the VMC group and in the VMC + NC group had disordered fur, were irritated easily or insensitive to irritation, ate little food and lost weight (data not shown). These conditions were improved in mice receiving the miR-1/133 mimics (data not shown). Figure 1A shows the specific myocardial staining, shown using antibodies against -actinin (green) and miR-1/133 (red).
The hearts from mice in the VMC group and NC group were bigger than those in the control and VMC + miR-1/133 mimics groups (Fig. 1B) and heart weight/body weight ratio was increased as well (Fig. 1C ). There were also spot-like necrotic areas on the surface of the hearts of mice in the VMC group and the VMC+NC group (Fig. 1B) .
MiR-1/133 mimics improved cardiac function of VMC mice
Compared with those in the control group, EF and FS of mice in the VMC and VMC + NC groups were significantly decreased (*p < 0.01), suggesting impaired cardiac function of VMC mice. However, treatment with miR-1/133 mimics improved EF and FS of VMC mice (#p < 0.05, ##p < 0.01; Fig. 2 ).
MiR-1/133 mimics attenuated pathological changes of VMC hearts
Compared with control group hearts, H&E staining showed that myocardia in VMC and VMC + NC groups were swollen and disordered, they were also infiltrated by inflammatory cells in the myocardial matrix. MiR-1/133 mimics reduced the edema of cardiomyocytes, improved arrangements, and diminished inflammatory cell infiltrate in the myocardial matrix (Fig. 3A) .
MiR-1/133 mimics reduced cardiomyocyte apoptosis
TUNEL staining showed increased numbers of brown nuclei in the VMC and VMC + NC groups compared with those in the control group (**p < 0.01), revealing increased cell death. MiR-1/133 mimics significantly reduced the number of brown nuclei (##p < 0.01), indicating decreased cell death. The VMC+NC group had the highest rate of apoptosis while the control group had the lowest (Fig. 3B, C) .
MiR-1/133 mimics improved expression of miR-1 and miR-133 in VMC hearts
qRT-PCR data showed that the relative expression of miR-1 and miR-133 in mouse hearts of the VMC and VMC + NC groups was significantly decreased compared to the control group (*p < 0.05), but miR-1/133 mimics increased the expression of miR-1 and miR-133 (#p < 0.05; Fig. 4A ).
MiR-1/133 regulated the mRNA expression of apoptosis-related genes Bax, Bcl-2 and caspase-9 in VMC hearts
The relative expression of pro-apoptosis-related genes Bax (**p < 0.01), and Casp9 
MiR-1/133 regulated the relative expressions of ion channel genes Kcnd2, Kcnj2, Irx5 and á1c in VMC hearts
Compared with those in the control group, the relative expression of Kcnd2 and Kcnj2 in the VMC and VMC + NC groups were significantly down-regulated as revealed by qRT-PCR data (*p < 0.05), which was attenuated by miR-1/133 mimics interference (#p < 0.05). Also, the relative expression of Irx5 and α1c (Cacna1c) was increased in VMC and VMC + NC groups compared with the control group (*p < 0.01), and this increase was suppressed by miR-1/133 mimics interference (#p < 0.05; Fig.   4C ). Fig. 5 ).
MiR
Discussion
MiRs have been shown to be implicated in a variety of human diseases, and may serve as potential bio-markers in certain diseases once released into the circulatory system [13] . Currently, more than 100 miRs have been identified in myocardial cells, and some, if not all, were dysregulated in heart diseases [14, 15] . MiR-1 and miR-133, which translate together in a bicistronic way [16] , are specific to muscle and are abundant in the heart [17, 18] . MiR-1 and miR-133 play an important role in normal cardio genesis [19] and in the pathogenesis of several cardiovascular diseases including myocardial ischemia-reperfusion injury [11] , cardiac hypertrophy [20, 21] , arrhythmia [22] , and myocardial infarction [23] . 
Viral invasion of myocardial cells causes persistent chronic inflammation,
subsequently resulting in myocardial cell hypertrophy, myocardial cell apoptosis, and myocardial fibrosis [24] [25] [26] . Therefore, the progression of VMC will eventually lead to heart failure and fatal arrhythmias, which is linked to sudden death. In agreement with the above findings, in the present study, the VMC mice induced by CVB3 Therefore, it is possible that these miR1/133-induced changes contributed to the improved cardiac function and pathology of VMC mice by miR1/133 mimics. In addition, the current findings demonstrate that miR-133 expression was inversely proportional with the expression of Casp9 and was in line with a previous study identifying caspase-9 as a target of miR-133 [27] .
Viral myocarditis patients display different arrhythmias, and severe arrhythmia can cause sudden cardiac death. Electrical remodeling and myocardium structural remodeling are the main mechanisms leading to arrhythmia [28] , which is associated with changes in the activity of ion channels present on the myocardial cell membrane [29] , including potassium and calcium ion channels. Although many miRs are expressed abnormally in many heart diseases, there are few reports regarding the relationship between miR-1 and miR-133 and the activity of potassium ion channels and calcium ion channels in VMC. For example, miR-1 and miR-133 were shown to be involved in the regulation of Kv4.2 and Kir2.1 expression [30] , the latter of which is the main component of Ik1 and is linked to arrhythmia [31] . Also, the aberrant expression of miR-1 influenced the activity of Ik1 and its expression [32, 33] . Kir2.1, which is the main potassium channel subunit,plays important roles in initiating and maintaining resting membrane potential of cardiomyocytes [34] , is encoded by Kcnj2, and Kcnj2 was targeted by miR-1 [3] . Therefore, the aberrant expression of miR-1 could cause abnormality in the structure and function of potassium channels, influencing membrane potential stability, and result in arrhythmia. In addition, the potassium channel subunit Kv4.2, the main component of Ito, is rich in cardiomyocytes, and is encoded by the Kcnd2 gene. Irx5, a transcriptional repressor of Kcnd2, and regulated potassium ion current and repolarization of action potentials. MiR-1 was found to target Irx5 and thus influenced the expression of Kcnd2 [35] . In the present study, it was observed that the aberrant expression of Kcnd2 and Kcnj2 in VMC cardiomyocytes, which can result in a change of potassium ion concentration and influence membrane potential, and therefore may contribute to arrhythmia. In line with the above reports, it was also shown herein that there was a negative correlation between miR-1 and Irx5. Therefore, it was believed that miR-1 improved arrhythmia at least in part through mediating the expression of Kcnd2 and Kcnj2 and thus, regulating potassium concentrations. In addition, the L-type calcium channel subunit α1c is the main calcium ion channel in myocardium and plays an important role in stabilizing calcium concentration in the cell and maintaining action potential repolarization. α1c was identified as a potential target of miR-133 [7] , which was consistent with the present findings that demonstrated a negative correlation between miR-133 and α1c. Taken together, it was speculated that miR-1 and miR-133 reduced arrhythmia by mediating the expression and activity of ion channels, and could serve as potential anti-arrhythmic targets.
Conclusions
In summary, this study reports that miR-1/133 mimics ameliorate cardiac function in VMC mice. Mechanistically, miR-1/133 mimics reduce cardiomyocyte apoptosis by regulating the expressions of apoptosis-related genes, improves arrhythmia through regulating the expressions of calcium and potassium ion channel genes of cardiomyocytes, and diminishes cardiac fibrosis in VMC mouse hearts. Therefore, miR-1/133 may serve as a potential therapeutic target for treatment of VMC in clinics. GAPDH was used as an internal reference, and data were normalized to the control group. N = 10, *p < 0.05, **p < 0.01 vs. control group, # p < 0.05 vs. VMC and VMC + NC groups; for other abbreviations -see text.
